Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats
Authors:
- 1 March 2014
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 727, 60-65
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Program of Hunan Province (2012FJ4297)
- National Natural Science Foundation of China (81200590)
- Ministry of Education of the People's Republic of China (20124324120005)
This publication has 36 references indexed in Scilit:
- Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptomeProceedings of the National Academy of Sciences, 2013
- Metabolic Effects of Chronic Sleep Restriction in RatsSLEEP, 2012
- Sleep: A Health ImperativeSLEEP, 2012
- Sleep duration and cardiometabolic risk: A review of the epidemiologic evidenceBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Chronic Sleep Disturbance Impairs Glucose Homeostasis in RatsInternational Journal of Endocrinology, 2010
- Effects of Sleep Fragmentation on Glucose Metabolism in Normal SubjectsChest, 2010
- A comprehensive definition for metabolic syndromeDisease Models & Mechanisms, 2009
- The metabolic consequences of sleep deprivationSleep Medicine Reviews, 2007
- Association of Sleep Time With Diabetes Mellitus and Impaired Glucose ToleranceArchives of internal medicine (1960), 2005
- Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass IndexPLOS Medicine, 2004